What it is
GHK-Cu is a short peptide bound to copper. Its peptide, GHK, is found naturally in human blood, and its level is reported to fall with age. GHK-Cu has two routes, on the skin and by injection, and the two have separate evidence.
What makes it distinct
The two can't be compared. A cream is measured by how concentrated it is; an injection, in milligrams. Tidepath checks neither: there's no checked dose range for an injection, and a cream couldn't be checked against one. The FDA notes there are limited data in people on the safety of injected GHK-Cu. It also notes a possible risk of immune reactions (immunogenicity) to compounded injections (mixed from their ingredients by a pharmacist or doctor), because of the potential for the peptide to clump together (aggregation) and for impurities related to it.
Open questions
- GHK-Cu (bound to copper) and plain GHK are related but not the same chemical, so Tidepath asks which you mean.
- How long an injection lasts in the body (pharmacokinetics). We found no measured half-life (the time it takes for half a dose to clear) in people. Tidepath doesn't chart its levels. A 2026 review says no formal studies have been reported that track the copper-bound form through the body.
- Whether it helps hair. A 2026 review describes a small study in people in which a GHK-Cu serum was reported to give more and thicker eyebrow hairs than a serum without it. The review notes the study didn't confirm the peptide's chemical form or how much of it got into the skin. A 2025 study that reported hair regrowth gave copper peptides, without saying which, together with minoxidil and dutasteride, drugs that work on their own. It had no control group, so it can't show what the copper peptides added.
- Whether it affects ageing. The natural level of GHK, its peptide, is reported to fall with age, which is why Tidepath lists it under Longevity. Human studies haven't proven that it slows ageing inside the body. Most of the randomized trials in people are small tests of face creams, and a 2026 review calls the older skin reports small or incompletely characterized.
More in Repair and recovery peptides